Johnson immediately put those regions into a new Tier 4 restriction level, upending Christmas plans for millions. Italy's Foreign Minister Luigi Di Maio said on his Facebook page that the government was about to sign a measure to suspend flights from the UK .
The British Prime Minister announced that from Sunday areas in the South East now in Tier 3 will be moved into a new Tier 4 - effectively returning to the lockdown rules of November. "There's no evidence to suggest it is more lethal or causes more severe illness", Mr Johnson said. In addition, there were 173,263 new cases reported over the past seven days - a rise of 48,275, or 38.6 percent, from the seven days prior to that.
More than a dozen states said they were told by the federal government that next week's shipment of the Pfizer-BioNTech vaccine would be 20-to-40% less than originally projected. "I'm the one who approved forecast sheets". Perna did say "we remain on track to allocate around 20 million doses of vaccine to all jurisdictions by the end of December, with distribution of those doses pushing into the first week of January".
On Nov 24 Nov, Malaysia announced that it would acquiring its initial supply for 12.8 million doses of Covid-19 vaccine from Pfizer to meet 20 per cent of its immunisation needs or 6.4 million people for free. In a note Wednesday, Bernstein analysts said they expect 200 million Americans will be vaccinated against the novel coronavirus by May 31, and that the people remaining at that point will either have refused the vaccine or found themselves ineligible.
In response to the government's decision not to expand lockdowns, Horwath said on Friday that "the longer that Ford waits, the longer that he dithers and delays, the more out of control this pandemic gets". Provincial data showed 895 people were hospitalized as a result of COVID-19 on Saturday, with 256 in intensive care and 146 on ventilators. The lockdown measures will be re-assessed in the new year.
It is assumed that the FDA may make this decision as early as Friday. Very few participants who received the vaccine in either trial got sick with COVID-19 and nearly none got seriously ill. And because each vaccine requires the administration of two doses, the existing agreements will cover less than half the USA population. The vaccines appear to be similarly effective.